Advertisement

The FDA OKs NeuroMetrix's Sensus pain management system for the U.S. market.

NeuroMetrix logo

NeuroMetrix (NSDQ:NURO) landed FDA clearance for its Sensus pain management system, a non-invasive transcutaneous electrical nerve stimulator designed to relieve the symptoms of diabetic neuropathy.

The Sensus pain management system offers relief and management of chronic intractable pain in the lower leg and foot. Patients can wear the device under clothing thanks to its light weight and low profile, according to NeuroMetrix.

Advertisement
Advertisement